February 17, 2009 Diagnostic Imaging. Mo-99 production resumes at troubled European isotope reactor By Paula Gould The High Flux Reactor in Petten, the Netherlands, is back online after its lengthy unscheduled closure, following special approval from the Dutch Council of Ministers. The decision should allow supplies of molybdenum-99 to stabilize after six months of periodic shortages and avert an immediate supply crunch. Both other sites in Europe that produce Mo-99 are currently closed for routine maintenance. "With the restart of the HFR, it is expected that within a few days there will be sufficient availability of medical isotopes for the treatment of patients worldwide," said a statement from the Nuclear Research and Consultancy Group (NRG), the company that runs the Petten reactor.
See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC